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Four anticarcinogens (oltipraz, a-tocopherol, P-carotene 
and phenethylisothiocyanate [PEITC]) were studied with 
respect to their effects on oesophageal, gastric, colonic and 
hepatic (i) glutathione (GSH) content, (ii) glutathione S- 
transferase (GST) enzyme activity, (iii) GST isoenzyme 
levels, and (iv) glutathione peroxidase (GPx) enzyme 
activity in male Wistar rats. GST enzyme activity was 
significantly increased in oesophagus (1.9 X) and colon 
(1.2 X) by PEITC and in liver (1.4X) by oltipraz. GST 
Alpha was doubled in the liver by oltipraz, a-tocopherol 
and PEITC. GST Mu levels were increased by P-carotene 
and PEITC in stomach and liver, by oltipraz in liver and 
by a-tocopherol in stomach. PEITC induced colonic GST 
Pi levels (1.3 X). GSH content was induced in liver by 
oltipraz (1.4X) and a-tocopherol (1.2X) and in colon 
by PEITC (1.6 X). Each of the anticarcinogens tested 
increased GPx activity at one or more sites: Se-dependent 
and total GPx activities were induced in 31.3% and 37.5% 
of all possibilities, respectively. Major induction in total 
GPx was found in stomach by a-tocopherol (1.8 X ). In 
conclusion our data demonstrate that dietary administra­
tion of oltipraz, PEITC, a-tocopherol and p-carotene, may 
exert chemopreventive effects in the digestive tract of the 
rat by enhancing GST, GPx, and, to a lesser extent, 
GSH levels.
Introduction
There is considerable interest in identifying synthetic or 
dietary compounds which may possess anticarcinogenic 
properties (1). Vegetables and fruit contain a large number 
of inhibitors of carcinogenesis, including phenols, indoles, 
aromatic isothiocyanates, ascorbic acid, tocopherols and 
carotenes (2,3). Therefore it is recommended to daily consume 
a variety of fruits and vegetables. We are in search of a 
possible mechanism explaining the anticarcinogenic properties 
of some of these compounds, in particular those present in 
cruciferous vegetables.
Phenethylisothiocyanate (PEITC*) is a naturally occurring 
compound, present as its glucosinolate precursor in certain 
cruciferous vegetables, such as Chinese cabbage, Brussel 
sprouts, watercress and radishes (4,5). It is formed through 
hydrolysis of gluconasturtiin by myrosinase (6 ). PEITC was 
shown to inhibit the metabolism and carcinogenicity of
* Abbreviations: CYP, cytochrome P450; GPx, glutathione peroxidase; GSH, 
glutathione; GST, glutathione S-transferase; PEITC, phenethylisothiocyanate; 
Se-GPx* selenium-dependent glutathione peroxidase; t-GPx, total glutathione 
peroxidase.
nitrosamines and poly cyclic aromatic hydrocarbons in various 
organs of the rat, such as lung, oesophagus and liver (3,7-9), 
and it reduced the incidence and size of adenomas and 
carcinomas (3,10,11).
a-Tocopherol, one of the carotenoids, is an antioxidant and 
free radical scavenger, but epidemiologic evidence for its 
chemopreventive action is inconsistent. a-Tocopherol reduced 
the production of carcinogenic Af-nitroso compounds from 
nitrites and amides, and it is one of the most important 
antioxidants in lipid membranes. It inhibits the development 
of chemically induced tumours in experimental animals ( 12). 
Conclusions from the few cross-sectional studies are somewhat 
contradictory as reviewed by Knekt et al. (13). Several case- 
control studies showed that a-tocopherol levels in blood were 
inversely correlated with cancers of breast, lung, stomach, 
pancreas and urinary organs (14-17). In prospective studies, 
a similar correlation was found for liver and lung (18), while 
other studies do not show a significant difference between 
cases and controls (13,15,17).
p-Carotene is the most abundant of the carotenoids, which 
are found in dark-green leafy vegetables, carrots, and yellow 
or red fruits and vegetables. p-Carotene is a precursor of 
vitamin A, which plays a role in vision, growth, reproduction, 
and control of epithelial growth and differentiation. Epidemio­
logical studies have provided strong evidence for a protective 
role of P-carotene against certain epithelial cancers, in particu­
lar those of the respiratory tract and oesophagus (19,20 and 
references therein). Daily consumption of vegetables with 
high levels of P-carotene was reported to diminish the risk of 
cancer of lung, colon, stomach, prostate and cervix (2 1 — 
23). p-Carotene protected rats and mice against experimental 
tumours at various sites such as stomach, lung, colon, skin 
and buccal mucosa (12,24-26).
Oltipraz, 5-(2-pyrazinyl)-4-methyl~l,2-dithiole-3-thione, is 
a substituted dithiolthione which was used in humans as an 
antischistozomal drug (27). Dithiolthiones occur in cruciferous 
vegetables. Oltipraz was shown to protect against acute and 
chronic toxicities of structurally diverse agents in multiple 
target organs (for review, see 28). In addition, it was found to 
inhibit carcinogenesis induced by benzo[a]pyrene, diethyl- 
nitrosamine and uracil mustard in lung and forestomach 
of mice (29), and azoxymethane-induced colon cancer in 
rats (30,31).
The mechanism of action of the above mentioned inhibitors 
of carcinogenesis are poorly understood. One method of action 
may be an enhancing effect on carcinogen detoxification 
systems, such as glutathione S-transferases (GSTs) (for 
review, see 2). Animals fed diets containing high concentrations 
of cruciferous vegetables or other anticarcinogens showed 
elevated GST-activity (32,33). The soluble GSTs are a gene 
family of dimeric enzymes comprised of four classes: Alpha, 
Mu, Pi and Theta (34). They catalyze the binding of a large 
variety of electrophiles to the sulphydryl group of glutathione 
(GSH). Since the reactive ultimate carcinogenic forms of
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Table I. Daily food consumption, unticarcinogen intake and gain in body weight of male Wistar rats receiving diets supplemented with oltipraz, cx-tocopheiol, 
p-carotene or PHITC
Treatment group (n =  8) Dose (% w/w)
Control
Oltipraz
a-Tocopherol
p-Carotene
PEITC
0.030
0.020
0.020
0.045
Food consumption 
(g/day) intake
20.1 ±0.7 
18.9±0.5
18.5 ±0.2
19.5 ±0.3 
17.9±0.3a
Total anticarcinogen 
(mg/day.kg body wt)
Gain in body wt 
(g/day)
28.5±0.8
18.5±0.2
19.4±0.3
40.4±0.6
3.9±0.2 
2.9 ±0 .31 
3.4 ±0.3 
3.6 ±0,4 
2.6±0.3U
Values given are means ±  SEM. The one-tailed Wilcoxon rank sum Lest was used to assess statistical significance of differences between control and treated 
groups: aP  <  0.05.
Table II. Effects of oltipraz, a-tocopherol, p-carotene or PEITC on oesophageal, gastric, colonic and hepatic glutathione S-transferase activity in rats
Treatment group {n = 8) Glutathione S-transferase activity (nmol/min.mg protein)
Oesophagus Stomach Colon Liver
Control 22±3 142± 14 68±5 1277 ± 113
Oltipraz 27 ±  1 154±9 75 ±3 !760±109c
a-Tocopherol 25 ± 4 148 ±8 74±7 1094 ±68
p-Carotene 27 ±3 138± 12 74±7 1330 ±46
PEITC 41 ± 3 C 167 ±  16 84 ± 6 “ 1376±58
CP <  0.005.
Table III. Effects of oltipraz, a-tocopherol, P-carotene or PEITC on oesophageal, gastric, colonic and hepatic glutathione S-transferase Alpha levels in rats
Treatment group (n =  8) Glutathione S-transferase Alpha level (ng/mg protein)
Oesophagus Stomach Colon Liver
Control ND 198±5 ND 8349 ±225
Oltipraz ND 209± 16 ND I6702±687c
a-TocopheroI ND 196± 10 ND 14583 ± 1786b
p-Carotene ND 198±6 ND 7921 ±473
PEITC ND 199 ±12 ND 18724±988c
bP <  0.01 and CP <  0.005; ND, not detectable.
T&ble IV. Effects of oltipraz, a-tocopherol, p-carotene or PEITC on oesophageal, gastric, colonic and hepatic glutathione S-transferase Mu levels in rats
Treatment group (n =  8) Glutathione S-transferase Mu level (ng/mg protein)
Oesophagus Stomach Colon Liver
Control 2878 ± 290 11934±735 2603 ±323 30769 ±781
Oltipraz 3068 ± 622 13992± 985 3290±228 42840 ±202 Ie
a-Tocopherol 3265 ± 312 13857 ± 863a 2807±255 34319± 3390
P-Carotene 2 9 5 6 ± 4 1 1 13757 ± 905a 3221 ±133 37586±2395a
PEITC 3523±313 13399±515a 2961 ±193 44980±905c
aP  <  0.05, hP <  0.01 and CP <  0.005.
chemical carcinogens are electrophiles, GST takes considerable 
importance as a mechanism for carcinogen detoxification
(34). Enhancement of the activity of this system by dietary 
anticarcinogens could result in a more efficient elimination of 
carcinogens, leading to cancer prevention.
Another parameter of importance in inhibiting carcino­
genesis is prevention of oxidative damage by glutathione 
peroxidases (GPxs). GPxs are enzymes that catalyze the
reduction of organic hydroperoxides and hydrogen peroxide 
(35). Two major types of GPx have been identified (35), a 
selenium-dependent form which is active with both organic 
hydroperoxides and hydrogen peroxide and a selenium- 
independent form which has no activity towards hydrogen 
peroxide and mainly comprises of GSTs (35).
The present study was designed to investigate the effects 
of dietary oltipraz, a-tocopherol, p-carotene and PEITC on
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Table V. Effects of oltipraz, a-tocopherol, P-carotene or PEITC on oesophageal, gastric., colonic and hepatic glutathione S-transferase Pi levels in rats
Treatment group (/t — 8) Glutathione S-transferase Pi level (ng/mg protein)
Oesophagus Stomach Colon Liver
Control ND 984±55 1001 ±27 ND
Oltipraz ND 1028 ±142 1036± 17 ND
a-Tocopherol ND 1033±80 1035 ±44 ND
P-Carotene ND 1035 ±71 1024 ±48 ND
PEITC ND 1018±90 1303±65c ND
CP <  0.005; ND, not detectable
Table VI. Effects of oltipraz, a-tocopherol, p-carotene or PEITC on oesophageal, gastric, colonic and hepatic glutathione levels in rats
Treatment group (n = 8) Glutathione (nmol/mg protein)
Oesophagus Stomach Colon Liver
Control 10±2 18 ±  3 7 ± I 47 ± 3
Oltipraz 14 ¿ 4 16±2 9 ±  I 6 4 ± 6 a
a-Tocopherol !2±3 18±2 9 ±2 5 8 ± 2 b
p-Carotene 12±3 13±3 10 ±  3 4 2 ± 2
PEITC 16±3 20±2 11 ± 2 a 4 8 ± 5
aP <  0.05 and hP < 0 .0 1 .
Table VII. Effects of oltipraz, a-tocopherol, P-carotene or PEITC <nn oesophageal, gastric, colonic and hepatic selenium-dependent glutathione peroxidase
activity in rats
Treatment group (/? -  8) Selenium-dependent glutathione peroxidase activity* (nmol/min.mg protein)
Oesophagus Stomach Colon Liver
Control 236 ±23 1574 3:165 208 ±  11 1364 ±80
Oltipraz 321 ± 3 1 “ 1855 ±28 2 4 4 ± 7 a 1598± Î21
a-Tocopherol 296±31 2098 ± 294 248 ±  20 1698 ±8 Ia
p-Carotene 284±20 1738 ±202 206±  17 1736±32c
PEITC 268± 12 2403 ±  2 12C 244± 19 1548 ±  82
:,:Hydrogen peroxide was used as substrate; iXP < 0.05, bP < 0.01 and LP <  0.005.
Table VIII. Effects of oltipraz, a-tocopherol, p-carotene or PEITC on oesophageal, gastric, colonic and hepatic total glutathione peroxidase activity in rats
Treatment group (/i = 8) Total glutathione peroxid ase activity* (nmol/min.mg protein)
Oesophagus Stomach Colon Liver
Control 194+10 1213± 115 216±  16 1148 ±71
Oltipraz 261 ± 7 “ 1360± 114 239 ± 8 1248 ±46
a-Tocopherol 221 ± 11 2176±249c 254 ± 14() 1278 ±56
P-Carotene 222 ± 15 1646 ±229 218±  16 1360±56a
PEITC 247 ± 5 C 2174±  190c 220 ±23 1334±73
*t-Butyl hydroperoxide was used as substrate. 11P < 0.05, < 0.01 and CP < 0.005.
glutathione S-transferases, glutathione peroxidase and gluta- ^  either the basal diet (control group) or one of the four experimental diets.
thione in rat oesophagus, colon, stomach and liver. Food and water were available ad libitum . Food cups were replenished every 2-3 days. Food consumption and gain in body weight were recorded daily.
After 2 weeks the rats were killed by decapitation.
Materials and methods Diets
Animal treatment
Fourty male Wistar rats (178 ± 8 g; Central Laboratory Animal Centre, 
University of Nijmegen, The Netherlands) were housed in pairs on wooden 
shavings in macrolon cages, maintained at 20-25°C and 30-60% relative 
humidity. A ventilation rate of seven air cycles/h and a 12 h light/dark cycle 
were used. The rats were randomly assigned to one of the dietary treatment 
groups, All groups were fed powdered RMH-TM lab chow (Hope Farms, 
Woerden, The Netherlands). After acclimatization for 7 days the animals were
Compounds and dose levels used were selected based on studies by others, 
showing anti mutagenic and/or anticarcinogenic properties (9,30,36,37). The 
diets were prepared by supplementation with either 0.03% (w/w) oltipraz 
(kindly provided by Rhone Poulenc Rorer, Vitry, Alfortville, France), 0,02% 
(w/w) a-tocopherol (Sigma Chemical Company, St Louis, MO, USA), 0.02% 
(w/w) (i-caroiene (Sigma), or 0,045% (w/w) phenethylisothiocyanate (PEITC; 
Sigma). A food processor was used to obtain a homologous mixture of test 
compound and powdered lab chow.
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Tissue preparation
All handlings were performed on ice. After decapitation the oesophagus, 
stomach, colon and liver were excised. Colon and stomach were slit longi­
tudinally and the contents were removed by washing with cold buffer A 
C0.25 M saccharose, 20 mM Tris, 1 mM dithiothreitiol, pH 7.4). The organs 
were directly frozen in liquid nitrogen and stored at -20°C  until use. For 
preparation of the cytosolic fraction the tissue was thawed quickly using cold 
running water. The mucosal surface of stomach, intestine and colon was 
collected by scraping with a scalpel and the mucosal scrapings were homo­
genized in buffer A (4 ml/g tissue) in a glass/glass Potter-Elvehjem tube. 
The liver was homogenized in buffer A (4 ml/g tissue) with ten strokes at 
1000 r.p.rn. of a motor-driven glass/Teflon homogenizer (Braun, Germany). 
The homogenate was centrifuged at 9000 g (4°C) l'or 30 min. The resulting 
supernatant fraction was transferred to an ultracentrifuge tube and spun at 
150 000 g (4°C) for 60 min. The oesophagus was homogenized in 5 ml buffer 
A per gram tissue in a glass/glass Potter-Elvehjem tube. These homogenates 
were centrifuged at 150 000 g for 60 min (4°C). Aliquots of the 150 000 g 
supernatant, representing the cytosolic fraction, were frozen in liquid nitrogen 
and stored at -80°C.
Assays
Protein concentration was assayed in quadruplicate by the method of Lowry 
et al. (38) using bovine serum albumin as the standard. GST activity was 
determined in triplicate according to Habig et aL (39), using l-chloro-2,4- 
dinitrobenzene (CDNB) as substrate. GST isoenzyme levels were determined 
as described before (33). In short, cytosolic fractions were subjected to sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (11% acrylamide, w/v), 
subsequent to Western blotting, using a semi-dry blotting system (Novablot II, 
Pharmacia, Uppsala, Sweden). Western blots were incubated with monoclonal 
antibodies against human GST class Alpha, Mu, and Pi. Class Alpha antibodies 
react with rat GST subunit 1, class Mu antibodies recognize rat GST subunits
3 and 4, and class Pi antibodies reacl with rat GST subunit 7. The specific 
binding of the monoclonal antibodies to the isoenzymes was detected with 4- 
chloro-l-naphthol after incubation with peroxidase-conjugated rabbit anti­
mouse immunoglobulin as second antibody (Dakopatts, Glostrup, Denmark). 
Staining intensity on the immunoblots was quantified using a laser densitometer 
(Ultroscan XL, LKB, Bromma, Sweden). Known amounts of purified GSTs 
were run in parallel with the experimental samples and served as standards 
for the calculation of the absolute amounts of these isoenzymes in the cytosolic 
fragments. Total glutathione was quantified by high performance liquid 
chromatography after reaction with monobromobimane, as described before 
(33). In ihis assay oxidized glutathione present is reduced by adding sodium 
borohydride to the reaction mixture. Glutathione peroxidase enzyme activity 
was measured with hydrogen peroxide and t-butylhydroperoxide (Sigma) as 
substrates, essentially as described by Howie et al. (40).
Statistical analysis
The Wilcoxon rank sum test with Bonferroni correction for multiple testing 
was used to assess statistical significance of differences between experimental 
and control groups: aP <  0.05, bP <  0.01 and CP <  0.005.
Results
Daily food consumption, anticarcinogen intake and gain in 
body weight are given in Table I. In the PEITC group food 
consumption was significantly reduced, but total anticarcinogen 
intake was high. At termination of the experiment, the daily 
gain in body weight for the oltipraz and PEITC group was 
significantly lower as compared with the control group.
Table II shows the effects of the anticarcinogens on GST 
activity in the four organs investigated. PEITC induced GST 
activity in oesophagus and colon (1 .9 X and 1.2 X, respectively) 
and oltipraz had an inducing effect in the liver (1.4X).
In Tables III, IV and V the effects of the anticarcinogens 
on GST class Alpha, Mu and Pi isoenzyme levels are given. 
In control animals GST Alpha (Table III) was undetectable in 
oesophagus and colon, low in stomach (198 ±  5 ng/mg 
protein) and high in liver (8349 ±  225 ng/mg protein). In 
oesophagus, stomach and colon, none of the diets significantly 
influenced the GST Alpha expression. In liver, on the other 
hand, increased levels of GST Alpha were found after feeding 
oltipraz, a-tocopherol or PEITC (2 .0X , 1.7X and 2.2X , 
respectively) as compared with controls. GST Mu (Table IV)
was expressed at high levels in all tissues examined, but 
only gastric and hepatic GST Mu levels were modulated by 
anticarcinogens. Gastric GST Mu levels were increased by a- 
tocopherol, P-carotene and PEITC (1.2X, 1.2X and 1.1 X, 
respectively), and hepatic GST Mu levels were elevated 
by oltipraz, p-carotene and PEITC ( 1.4 X, 1 .2 X and 1.5 X, 
respectively). In control group GST Pi (Table V) was 
undetectable in oesophagus and liver, and low in stomach and 
colon (984 ± 55 and 1001 ± 2 7  ng/mg protein, respectively). 
Only in the colon PEITC induced GST Pi levels to 1303 ±
65 ng/mg protein.
Table VI shows the effect of the anticarcinogens on GSH 
content in the organs studied. Oesophageal and gastric GSH 
content was not significantly influenced by any of the anti­
carcinogens. Elevation of GSH content was seen by oltipraz 
and a-tocopherol (1.4X and 1.2 X, respectively) in liver 
and by PEITC in colon (1.6 X). No correlation between 
enhancement of GST and GSH levels was found.
In Tables VII and VIII, the data of glutathione peroxidase 
activity (GPx) are presented. Selenium-dependent (Se-GPx) 
and total GPx (t-GPx) were measured using hydrogen peroxide 
and t-butyl hydroperoxide as substrate, respectively. Interest­
ingly, GPx activities are highest in stomach, slightly lower in 
liver and lowest in oesophagus and colon. The anticarcinogens 
tested all increased either one of the activities at one or more 
sites. Se-GPx activity (Table VII) was increased by oltipraz in 
oesophagus (1.4X) and colon ( 1.2 X), by a-tocopherol and P- 
carotene in liver (1.2 X and 1.3 X, respectively) and by PEITC 
in stomach (1.5 X). Total GPx activity (Table VIII) was 
increased by oltipraz in oesophagus ( 1.3 X), by a-tocopherol 
in stomach and colon (1 .8 X and 1.2 X), by P-carotene in liver 
(1.2X) and by PEITC in oesophagus (1.3X) and stomach 
(1.8X).
Discussion
Consumption of vegetables and fruit can significantly decrease 
the risk of human cancer (41,42). A relationship between 
vitamin A and human cancer was first reported in 1941 by 
Abels et al (43), who documented low vitamin A levels in 
cancer patients, particularly in patients with gastrointestinal 
malignancies. The human diet contains a large number of both 
(pre)carcinogens as well as a variety of compounds that inhibit 
mutagenesis and/or carcinogenesis in laboratory models (44- 
46). This latter group consists of structurally diverse com­
pounds, of which the protective mechanisms are generally 
unresolved. Although prevention of cancer may be due to 
multiple mechanisms, one way of action of anticarcinogens 
may be an enhancing effect on carcinogen detoxification 
systems, such as glutathione S-transferases (GSTs). Fruits and 
vegetables that elevate tissue phase II enzyme levels in rodents 
can effectively block experimental carcinogenesis and increase 
the clearance of drugs in humans (1,2,32,47).
In rats receiving a diet containing oltipraz or PEITC the daily 
gain in body weight was lower as compared to the control group. 
In the PEITC group (receiving 2.7 |imol/g diet) reduced food 
consumption coincided with reduced weight gain. Reduced 
weight gain after feeding rats 6  |amol PEITC per gram of diet 
has been reported before (9). The oltipraz group (receiving 
300 p.p.m. in their diet) showed a lower daily gain in body 
weight, whereas there was a normal food intake. Rao et a l  (31) 
did not find any effect on body weight of a somewhat lower dose 
of oltipraz (200 p.p.m. for 2 weeks). No effect of oltipraz on
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food consumption has been reported before. During the course 
of the experiment no changes in behavioral pattern of the animals 
were observed. In addition to this, none of the organs studied 
showed any macroscopical sign of toxicity of the dietary additive 
at the end of the experiment. Therefore, we believe that the lower 
gain in body weight in the oltipraz group, despite a normal food 
intake may be the result of diminished absorption of macro­
nutrients in the gastrointestinal tract. No effect of p-carotene on 
body weight gain has been reported (25) in accordance with 
our results.
At present, more information about the effects of dietary 
anticarcinogens on oesophageal, gastric, colonic and hepatic 
GST activity is becoming available. In our study, oesophageal 
and colonic GST activity were increased by PEITC that may 
be of significance in the protection against oesophageal and 
colonic cancer. We could not find any effect of PEITC on 
hepatic GST activity, in accordance with earlier results of 
Smith et al. (37), who found that dietary intake of PEITC 
(1 and 3 |amol/g diet) did not significantly induce GST activity 
in liver. This suggests that the biological action of PEITC is 
not due to its effect on hepatic GSTs under these experi­
mental conditions. In male F344 rats, on the other hand, 
0.25 mmol/kg base weight of PEITC resulted in a slight 
increase of liver GST activity after 24 h (48), while a single 
dose of 1 mmol/kg decreased liver GST activity by a factor
1.5 (49). These differences might be due to species-specific 
and/or concentration-dependent effects, which make it virtually 
impossible to extrapolate from one study to another. We have 
not found any reports on effects of PEITC on oesophageal 
and/or colonic GST activity. The inducing effect of dietary 
oltipraz on hepatic GST activity we noticed is in agreement 
with results reported by others (50,51).
In addition to the measurement of GST activity it may be 
important to study changes in levels of isoenzymes, which 
may have different substrate specificities. The isoenzymes 
showed a tissue specific distribution. Class Alpha GSTs are 
abundant in liver and small intestine, whereas class Pi GSTs 
are well expressed in stomach, small- and large intestine 
(33,34). In contrast, class Mu enzymes seem to be less organ 
specific since they were detected at high levels in a wide 
variety of tissues. In our study, GST Alpha was not detectable 
in oesophagus and colon, and GST Pi was undetectable in 
oesophagus and liver, and none of the anticarcinogens had any 
effect on this. At two sites where GST activity was induced a 
significant increase in one or more classes of GST was 
observed. The increase in colonic GST activity by PEITC was 
parallelled by a rise in GST Pi level in the same order of 
magnitude, and dietary administration of oltipraz resulted in 
an increase in hepatic GST activity and higher GST Alpha 
and GST Mu levels. Higher doses of oltipraz (0.075%) were 
reported to induce GST Alpha, Mu and Pi levels in livers of 
Sprague-Dawley rats (52). In human hepatocyte cultures, GST 
Alpha, but not Mu was selectively and specifically elevated 
by oltipraz (53). In our study, PEITC increased oesophageal 
GST activity, but had no effect on any of the isoenzymes in 
this organ. In addition, GST isoenzyme levels were induced 
at some sites without significant change in overall GST activity. 
Administration of PEITC induced hepatic GST Alpha and Mu, 
and gastric GST Mu levels; a-tocopherol increased gastric 
GST Mu and hepatic GST Alpha levels; and P-carotene 
increased gastric and hepatic GST Mu levels, although no 
effects on GST activity were notified.
Only few data on effects on GSH levels of the anti­
carcinogens tested have been reported before. GSH is a very 
important physiological nucleophile which forms conjugates 
with reactive electrophiles, including carcinogenic nitrosam- 
ines (54). We found an induction of GSH in only three out of 
16 possibilities: (i) in colon by PEITC and (ii) in liver by 
oltipraz, which both parallelled increases in GST activity, and 
(iii) in liver by a-tocopherol. Oltipraz-induced hepatic GSH 
levels have been reported before by others (51).
Glutathione peroxidase (GPx), which utilizes GSH to cata­
lyze the reduction of hydroperoxides, is a cellular defence 
system against the deleterious effects of hydroperoxides 
(55,56). Each of the four anticarcinogens tested in our study 
induced GPx activity at one or more sites: at five out of 16 
(31%) sites for Se-dependent GPx and six out or 16 (38%) 
sites for total GPx. Therefore increase of GPx levels may 
significantly contribute to the overall effect of the compounds 
tested here. Again, there is little information available in the 
literature. Dietary a-tocopherol was reported to increase GPx 
activity in rat muscle but not in liver, lung, kidney and testes 
(57). In another study dietary a-tocopherol had no effect on 
GPx activity in rat liver and intestines (58).
Chemopreventive effects may be mediated by enzyme 
systems other than GSTs. Inhibition of enzymes involved in 
the bioactivation of pro-carcinogens may be equally important. 
The anti carcinogens tested in our study have previously been 
shown to be able to influence the phase I cytochrome P450 
(CYP) enzyme system as well. PEITC efficiently prevented 
the ethanol-induced elevation of CYP2E1 apoprotein and 
mRNA levels in rat liver (59). a-Tocopherol significantly 
decreased cytochrome P450 in rats (60). P-Carotene inhibited 
the cytochrome P450-mediated benzo[a]pyrene metabolism in 
rat liver (61). Finally, inhibition by oltipraz of aflatoxin B1 
metabolism in human primary cultures of hepatocytes was 
found to be mediated by inhibiting CYP1A2 and CYP3A4 (62).
It is therefore likely that these effects on cytochrome P450, 
in combination with enhancement of glutathione S-transferases, 
glutathione peroxidase and glutathione, are responsible for 
the chemoprotective character of the compounds tested in 
our study.
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